Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.

Smith TA, Idamakanti N, Marshall-Neff J, Rollence ML, Wright P, Kaloss M, King L, Mech C, Dinges L, Iverson WO, Sherer AD, Markovits JE, Lyons RM, Kaleko M, Stevenson SC.

Hum Gene Ther. 2003 Nov 20;14(17):1595-604.

PMID:
14633402
2.

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.

Smith TA, Idamakanti N, Rollence ML, Marshall-Neff J, Kim J, Mulgrew K, Nemerow GR, Kaleko M, Stevenson SC.

Hum Gene Ther. 2003 May 20;14(8):777-87.

PMID:
12804140
3.

In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

Smith T, Idamakanti N, Kylefjord H, Rollence M, King L, Kaloss M, Kaleko M, Stevenson SC.

Mol Ther. 2002 Jun;5(6):770-9.

4.

A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells.

Su EJ, Stevenson SC, Rollence M, Marshall-Neff J, Liau G.

J Vasc Res. 2001 Sep-Oct;38(5):471-8.

PMID:
11561149
5.

Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.

Jakubczak JL, Rollence ML, Stewart DA, Jafari JD, Von Seggern DJ, Nemerow GR, Stevenson SC, Hallenbeck PL.

J Virol. 2001 Mar;75(6):2972-81.

6.

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

Stevenson SC, Rollence M, Marshall-Neff J, McClelland A.

J Virol. 1997 Jun;71(6):4782-90.

7.

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.

Stevenson SC, Rollence M, White B, Weaver L, McClelland A.

J Virol. 1995 May;69(5):2850-7.

8.

Production of engineered IgM-binding single-chain antibodies in Escherichia coli.

Lee TK, Rollence ML, Hallberg PL, Oelkuct MS, Dodd SW, Nagle JW, Filpula DR.

J Ind Microbiol. 1995 May;14(5):371-6.

PMID:
7612215
9.

Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv.

Whitlow M, Filpula D, Rollence ML, Feng SL, Wood JF.

Protein Eng. 1994 Aug;7(8):1017-26.

PMID:
7809028
10.

An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.

Whitlow M, Bell BA, Feng SL, Filpula D, Hardman KD, Hubert SL, Rollence ML, Wood JF, Schott ME, Milenic DE, et al.

Protein Eng. 1993 Nov;6(8):989-95.

PMID:
8309948
11.

Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding.

Pantoliano MW, Whitlow M, Wood JF, Dodd SW, Hardman KD, Rollence ML, Bryan PN.

Biochemistry. 1989 Sep 5;28(18):7205-13.

PMID:
2684274
12.

The engineering of binding affinity at metal ion binding sites for the stabilization of proteins: subtilisin as a test case.

Pantoliano MW, Whitlow M, Wood JF, Rollence ML, Finzel BC, Gilliland GL, Poulos TL, Bryan PN.

Biochemistry. 1988 Nov 1;27(22):8311-7.

PMID:
3072018
13.

Engineering thermostability in subtilisin BPN' by in vitro mutagenesis.

Rollence ML, Filpula D, Pantoliano MW, Bryan PN.

Crit Rev Biotechnol. 1988;8(3):217-24.

PMID:
3145814
14.

Protein engineering of subtilisin BPN': enhanced stabilization through the introduction of two cysteines to form a disulfide bond.

Pantoliano MW, Ladner RC, Bryan PN, Rollence ML, Wood JF, Poulos TL.

Biochemistry. 1987 Apr 21;26(8):2077-82.

PMID:
3476160
15.

Proteases of enhanced stability: characterization of a thermostable variant of subtilisin.

Bryan PN, Rollence ML, Pantoliano MW, Wood J, Finzel BC, Gilliland GL, Howard AJ, Poulos TL.

Proteins. 1986 Dec;1(4):326-34.

PMID:
3329733

Supplemental Content

Loading ...
Support Center